SearchInput the word you want to find
- ABOUT JSMO
- HOME
- ABOUT JSMO
- 2015 Award Recipients
2015 Award Recipients
2015 Award Recipients
| Annals of Oncology Award | ||
|---|---|---|
| Name | Affiliation | Awarded Paper |
| Akira Inoue | Department of Respiratory Medicine, Tohoku University Hospital | Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin?paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) |
| Young Investigator Award | ||
| Name | Affiliation | Awarded Paper |
| Motoo Nomura | Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine | Comparison between NAC-S and CRT in overall survival for patients with esophageal squamous cell carcinoma (JCOG1406-A) |
| Masayuki Nagahashi | Division of Digestive and General Surgery, Niigata University Department of Medical Oncology, Niigata University | A lipid mediator, sphingosine-1-phosphate as a promising target for colitis-associated cancer |
| Takao Miyabayashi | Department of Respiratory Medicine, Niigata City General Hospital | A randomized phase Ⅱ trial of triplet or doublet antiemetic therapy in lung cancer patients receiving MEC （NLCTG1002） |
| Hideaki Bando | National Cancer Center Hospital East | Analysis of esophago-gastric cancer patients enrolled in NCI-CTEP-sponsored phase Ⅰ trials |
| Takayuki Nakagawa | Eisai Co., Ltd. Tsukuba Research Laboratories, Oncology-PCU | Lenvatinib in combination with golvatinib overcomes resistance to VEGFR inhibitor |
| Masanori Mori | Department of Medical Oncology, Seirei Hamamatsu General Hospital | Medical oncologists’ attitude toward end-of-life discussions: Effects of their experience, perceptions, and beliefs |
| Tatsunori Shimoi | Breast and Medical Oncology, National Cancer Center | Imaging mass spectrometry of novel drug in tissues: Distribution of unlabeled drug to support early phase clinical trial |
| Hidetoshi Hayashi | Department of Medical Oncology, Faculty of Medicine, Kinki University | Integrative algorithm to determine the metastatic carcinoma tissue of origin using next generation sequencing (NGS) |
※Titles omitted, listed in Japanese alphabetical order.
※Affiliations are listed as of the time of the award.
©Japanese Society of Medical Oncology All rights reserved.